Efficacy of 4 Weeks of Otago Exercise Programme in Improving Balance and Reducing Fall Risk in Persons with Diabetic Neuropathy
Abstract
Background: Numbness, tingling, pain and weakness are common in Diabetic Neuropathy patients and these symptoms often start in their feet before spreading proximally in a length-dependent manner. This results in a decrease in balance which leads to increased risk of fall and reduced quality of life. Otago Exercise Programme (OEP) is an individually tailored, home-based, balance and strength fall prevention programme that helps to improve balance in the elderly population. This study was conducted to determine if four weeks of OEP had any impact on balance and falls in diabetic neuropathy patients.
Materials and Method: A total of 32 participants aged between 40 and 70 years with diabetic neuropathy were randomly recruited from various hospitals of Kamrup Metro, Assam. OEP, which consists of 17 strength and balance exercises, was done for 4 weeks and the outcome measures were assessed using the Berg Balance Scale (BBS), Timed up and go test (TUG) and Falls Efficacy Scale (FES).
Results: Wilcoxon paired test was used to find any significant differences between pre- and post-intervention values of BBS, TUG and FES (p value < 0.001). The effect sizes (ranging from 0.86 to 0.89) indicated large effects for all three scales, suggesting substantial improvements in balance, efficacy, and mobility post-intervention.
Conclusion: OEP was found to be effective in improving balance in diabetic neuropathy, thus reducing the risk of falls in these patients.
How to cite this article:
Sangma A, Lakhotia S. Efficacy of 4 Weeks of Otago Exercise Programme in Improving Balance and Reducing Fall Risk in Persons with Diabetic Neuropathy. Chettinad Health City Med J. 2024;13(4):69-74.
DOI: https://doi.org/10.24321/2278.2044.202461
References
Nascimento OJ, Pupe CC, Cavalcanti EB. [Diabetic neuropathy]. Rev Dor [Internet]. 2016 [cited 2023 Jun 11];17(Suppl 1):46-51. Portugese. Available from: https://doi.org/10.5935/1806-0013.20160047 [Google
Scholar]
Feldman EL, Callaghan BC, Pop-Busui R, Zochodne DW, Wright DE, Bennett DL, Bril V, Russell JW, Viswanathan V. Diabetic neuropathy. Nat Rev Dis Primers [Internet]. 2019 [cited 2023 Jun 7];5(1):41. Available from: https://www.nature.com/articles/s41572-019-0092-1 [PubMed] [Google Scholar]
Bansal V, Kalita J, Misra UK. Diabetic neuropathy. Postgrad Med J [Internet]. 2006 [cited 2023 Jun 7];82(964):95-100. Available from: https://academic.oup.com/pmj/article/82/964/95/7045246 [PubMed] [Google Scholar]
Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, Colagiuri S, Guariguata L, Motala AA, Ogurtsova K, Shaw JE, Bright D, Williams R; IDF Diabetes Atlas Committee. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract [Internet]. 2019 [cited 2023 Jun 7];157. Available from: https://www.sciencedirect.com/science/article/pii/S0168822719312306 [PubMed] [Google Scholar]
D’Souza M, Kulkarni V, Bhaskaran U, Ahmed H, Naimish H, Prakash A, Tabreez S, Dahiya B, Thapar R, Mithra P, Kumar N, Holla R, Bb D, Kumar A. Diabetic peripheral neuropathy and its determinants among patients attending a tertiary health care centre in Mangalore, India. J Public Health Res [Internet]. 2015 [cited 2023 Jun 7];4(2):450. Available from: https://journals.sagepub.com/doi/full/10.4081/jphr.2015.450 [PubMed] [Google Scholar]
Jasmine A, Akila GV, Durai V, Rani MA, Shriraam V, Samya V, Gayathri T, Mahadevan S. Prevalence of peripheral neuropathy among type 2 diabetes mellitus patients in a rural health centre in South India. Int J Diabetes Dev Ctries [Internet]. 2021 [cited 2023 Jun 7];41(2):293-300. Available from: https://link.springer.com/article/10.1007/s13410-020-00885-6 [Google Scholar]
Darivemula S, Nagoor K, Patan SK, Reddy NB, Deepthi CS, Chittooru CS. Prevalence and its associated determinants of Diabetic Peripheral Neuropathy (DPN) in individuals having type-2 diabetes mellitus in rural South India. Indian J Community Med. 2019 Apr-Jun;44(2):88-91. [PubMed] [Google Scholar]
Callaghan BC, Cheng HT, Stables CL, Smith AL, Feldman EL. Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neurol [Internet]. 2012 [cited 2023 Jun 7];11(6):521-34. Available from: https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(12)70065-0/abstract [PubMed] [Google Scholar]
Flyvbjerg A, Holt RI, Cockram C, Goldstein BJ. Textbook of diabetes. 4th ed. Wiley; 2010. p. 615-31.
Bodman MA, Dreyer MA, Varacallo MA. Diabetic peripheral neuropathy [Internet]. StatPearls Publishing; 2024 [cited 2024 Nov 14]. p. 3-6. Available from: https://www.ncbi.nlm.nih.gov/books/NBK442009/ [PubMed] [Google Scholar]
Zilliox LA. Diabetes and peripheral nerve disease. Clin Geriatr Med [Internet]. 2021 [cited 2023 Jun 7];37(2):253-67. Available from: https://www.binasss.sa.cr/mayo2021/23.pdf [PubMed] [Google Scholar]
